Assisted Living Industry Looks At Future Of Alzheimer's - ALFA Submits Testimony On Alzheimer's Care, USA
The nation's leading organization of assisted living providers today urged the Senate Special Committee on Aging to look to assisted living providers for the model of care for victims of Alzheimer's disease.Richard Grimes, the CEO and president of the Assisted Living Federation of America (ALFA), submitted testimony to the committee as it launched hearings on the impact on Americans of the progressive brain disease.
Green Tea Prevents Deathly Plaque Formation In Parkinson's And Alzheimer's - First Results In The Test Tube And With Cell Models
The substance ECGC (Epigallocatechin-3-gallate) from green tea can redirect the deadly process which leads to the accumulation of protein aggregates in Parkinson's and Alzheimer's disease. EGCG modulates a cascade of protein misfolding in such a way that the formation of deadly plaques is interrupted, and harmless protein structures emerge instead.
New Strategy Against Alzheimer's Disease Following Unexpected Results From Study
Interrupting a signaling pathway in certain immune system cells in laboratory mice had the opposite effect researchers expected but opened the possibility of a new approach to treating Alzheimer's disease, according to an article in the journal Nature Medicine.The intervention targets the sticky plaque buildup that occurs in the brains of patients with Alzheimer's disease, using immune system cells (macrophages) from outside the brain.
Appealing The Death Sentence For Brain Cells
A new drug candidate discovered by Tel Aviv University researcher Prof. Illana Gozes may lead to an effective treatment against the debilitative Alzheimer's disease. This compound could also treat a number of diseases where patients suffer from cognitive deficits, such as schizophrenia and Parkinson's, by limiting damage to the brain.
Drugs Being Tested For Alzheimer's Disease Work In Unexpected And Beneficial Ways
Researchers at Mayo Clinic, with their national and international collaborators, have discovered how a class of agents now in testing to treat Alzheimer's disease work, and say they may open up an avenue of drug discovery for this disease and others.
Neuroscientists Make Alzheimer's Disease Advance, Queensland Brain Institute
Queensland Brain Institute (QBI) neuroscientists at UQ have discovered a new way to reduce neuronal loss in the brain of a person with Alzheimer's disease. Memory loss in people with Alzheimer's disease can be attributed to several factors. These include a build-up of the neuro-toxin Amyloid beta - the major component of amyloid plaques found in patients with Alzheimer's - and corresponding degeneration of a specific population of nerve cells in the basal forebrain.
Avid Radiopharmaceuticals Initiates First Phase II Trial Of Novel Compound For Imaging Alzheimer's Disease
Avid Radiopharmaceuticals, Inc. announced the start of a Phase II clinical trial studying 18F-AV-45, an investigational molecular imaging compound under development for imaging Alzheimer's disease. 18F-AV-45 is used with positron emission tomography (PET) to allow visualization of the amyloid plaque deposits in the brain that are characteristic of Alzheimer's disease. Amyloid plaque is thought to slowly accumulate in patients over years, eventually causing death of brain cells and dementia.
Study Outlines Misconceptions About Alzheimers, Australia
Better targeted education is needed to prevent misconceptions held by the general public about Alzheimer's disease, according to Queensland University of Technology researcher Dr Karen Sullivan. Registered psychologist and senior lecturer for the School of Psychology and Counselling in the Faculty of Health, Dr Sullivan has been studying people's misconceptions about the condition for the past five years, and said there were a number of things which people misunderstood about it.
Vaccine Triggers Immune Response, Prevents Alzheimer's
A vaccine created by University of Rochester Medical Center scientists prevents the development of Alzheimer's disease-like pathology in mice without causing inflammation or significant side effects.Vaccinated mice generated an immune response to the protein known as amyloid-beta peptide, which accumulates in what are called "amyloid plaques" in brains of people with Alzheimer's.
New Campaign Launched: Are You Worried About Your Memory? UK
Health Minister Ivan Lewis helped launch Alzheimer's Society's new public information campaign to raise awareness of dementia, its symptoms and the importance of getting an early diagnosis. Called Worried About Your Memory?, the campaign will prompt and help people to consider if their forgetfulness, or that of a friend or relative, is due to just poor memory or the beginning of a medical problem and encourage them to seek medical advice.